Stefan Kaufmann

Stefan Kaufmann became President and CEO of Olympus Corporation in 2023, making history as the first non-Japanese chief executive in the company's over 100-year history. A German national who previously led the endoscopic solutions division, Kaufmann represents the completion of Olympus's remarkable transformation from a diversified Japanese electronics company — known primarily for cameras — into a focused global medical technology leader. Olympus's dominance in endoscopy is extraordinary: the company holds approximately 70% of the global market for gastrointestinal endoscopes, the devices used to examine the digestive tract for cancer screening, diagnosis, and minimally invasive treatment. This near-monopoly position, built on decades of optical engineering expertise, provides exceptional pricing power and recurring revenue from disposable accessories and servicing. Under the transformation strategy initiated before Kaufmann and now accelerated under his leadership, Olympus sold its camera division (to Japan Industrial Partners) and its scientific solutions business, redirecting all resources to medical devices. Kaufmann's strategic priorities include expanding Olympus's presence in therapeutic (surgical) endoscopy, where devices are used to perform procedures rather than just diagnose; growing in urology, respiratory, and ENT endoscopy; and building a digital health platform that integrates AI-powered image analysis with Olympus scopes. His decisions on R&D investment allocation, M&A in surgical robotics, pricing strategy in the face of emerging Chinese competitors, and geographic expansion into underserved markets are the key drivers of Olympus's stock.